Gilger BC - Search Results

1

Sustained release cyclosporine therapy for bilateral keratoconjunctivitis sicca in a red wolf (Canis rufus).

Acton AE, Beale AB, Gilger BC, Stoskopf MK. Acton AE, et al. Among authors: gilger bc. J Zoo Wildl Med. 2006 Dec;37(4):562-4. doi: 10.1638/06-021.1. J Zoo Wildl Med. 2006. PMID: 17315447

2

Cellular immunity in dogs with keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine.

Gilger BC, Andrews J, Wilkie DA, Wyman M, Lairmore MD. Gilger BC, et al. Vet Immunol Immunopathol. 1995 Dec;49(3):199-208. doi: 10.1016/0165-2427(95)05471-5. Vet Immunol Immunopathol. 1995. PMID: 8746695

3

Eosinophilic keratoconjunctivitis in seven horses.

Yamagata M, Wilkie DA, Gilger BC. Yamagata M, et al. Among authors: gilger bc. J Am Vet Med Assoc. 1996 Oct 1;209(7):1283-6. J Am Vet Med Assoc. 1996. PMID: 8837652

4

Low-dose oral administration of interferon-alpha for the treatment of immune-mediated keratoconjunctivitis sicca in dogs.

Gilger BC, Rose PD, Davidson MG, Roberts SM, Miller T. Gilger BC, et al. J Interferon Cytokine Res. 1999 Aug;19(8):901-5. doi: 10.1089/107999099313433. J Interferon Cytokine Res. 1999. PMID: 10476936 Clinical Trial.

5

Effect of an intravitreal cyclosporine implant on experimental uveitis in horses.

Gilger BC, Malok E, Stewart T, Horohov D, Ashton P, Smith T, Jaffe GJ, Allen JB. Gilger BC, et al. Vet Immunol Immunopathol. 2000 Oct 31;76(3-4):239-55. doi: 10.1016/s0165-2427(00)00219-1. Vet Immunol Immunopathol. 2000. PMID: 11044557

6

Use of an intravitreal sustained-release cyclosporine delivery device for treatment of equine recurrent uveitis.

Gilger BC, Wilkie DA, Davidson MG, Allen JB. Gilger BC, et al. Am J Vet Res. 2001 Dec;62(12):1892-6. doi: 10.2460/ajvr.2001.62.1892. Am J Vet Res. 2001. PMID: 11763177 Free article.

7

A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis.

Gilger BC, Salmon JH, Wilkie DA, Cruysberg LP, Kim J, Hayat M, Kim H, Kim S, Yuan P, Lee SS, Harrington SM, Murray PR, Edelhauser HF, Csaky KG, Robinson MR. Gilger BC, et al. Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2596-605. doi: 10.1167/iovs.05-1540. Invest Ophthalmol Vis Sci. 2006. PMID: 16723476 Clinical Trial.

8

Effect of ophthalmic Nd:YAG laser energy on intraocular lenses after posterior capsulotomy in normal dog eyes.

Beale AB, Salmon J, Michau TM, Gilger BC. Beale AB, et al. Among authors: gilger bc. Vet Ophthalmol. 2006 Sep-Oct;9(5):335-40. doi: 10.1111/j.1463-5224.2006.00473.x. Vet Ophthalmol. 2006. PMID: 16939462

9

A topical aqueous calcineurin inhibitor for the treatment of naturally occurring keratoconjunctivitis sicca in dogs.

Gilger BC, Wilkie DA, Salmon JH, Peel MR. Gilger BC, et al. Vet Ophthalmol. 2013 May;16(3):192-7. doi: 10.1111/j.1463-5224.2012.01056.x. Epub 2012 Jul 31. Vet Ophthalmol. 2013. PMID: 22853450 Clinical Trial.

10

Treatment of immune-mediated keratitis in horses with episcleral silicone matrix cyclosporine delivery devices.

Gilger BC, Stoppini R, Wilkie DA, Clode AB, Pinto NH, Hempstead J, Gerding J, Salmon JH. Gilger BC, et al. Vet Ophthalmol. 2014 Jul;17 Suppl 1:23-30. doi: 10.1111/vop.12087. Epub 2013 Aug 1. Vet Ophthalmol. 2014. PMID: 23910236

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

173 results

Search Page